Record-Breaking Sleep Apnea Webinar Series Announced

SleepWorld Magazine announced today that, in mid-August, it will host the second presentation in its popular “Discoveries in Sleep Apnea” program, a series of webinars providing sleep clinicians with rapid access to practical, cutting-edge discoveries via presentations from recognized leaders in sleep medicine. Daniel J. Gottlieb, MD, MPH and Associate Professor at Harvard Medical School, will present “Sleep Apnea and Cardiovascular Disease: Could Excessive CPAP Explain the Negative Clinical Trials?” at 8 p.m. EDT on Tuesday, August 13 and again at 1 p.m. EDT on Wednesday, August 14.

Accessible to clinicians worldwide, “Discoveries in Sleep Apnea” is a virtual lecture series focusing on innovations and physiologic discoveries in sleep breathing disorders and is presented by renowned sleep medicine researchers from leading institutions. The series is sponsored by SleepRes, Inc.

“Via the traditional route of annual medical meetings, it can take years for new discoveries in sleep medicine to be shared with clinicians,” said William Noah, MD and founder of SleepRes. “In private practice, 90 percent of what we see in sleep medicine are patients needing treatment for sleep apnea, yet in recent years, only a small percentage of the lectures at the annual medical meetings address this topic. The purpose of this new series is to present practice-changing discoveries to sleep clinicians on the front lines in a much timelier fashion.”

Each of the webinars in “Discoveries in Sleep Apnea” will be presented twice, making it possible for any participant worldwide to view each presentation live. With the series running into early 2025, each weekday lecture will be offered at 8 p.m. EDT on the first day, which is morning time in Asia and Australia, and again at 1 p.m. EDT the next day, which is evening time in Europe and Africa. Each of the virtual lectures will be presented free of charge and be followed by a Q&A session, with CME/CE credits available at a minimal cost.

Dr. Gottlieb’s presentation in mid-August will highlight recent evidence of possible harm from the excessive airway and lung pressures of continuous positive airway pressure (CPAP), as well as the clinical implications of these findings.

In the following months, Richard Berry, MD and Professor at the University of Florida, will present “Auto-PAP (APAP) Treatment: Challenges and Opportunities” on September 18 and 19, while M. Safwan Badr, MD, MBA and Professor and Chief of Medicine at Wayne State University, will present “Central Apnea: Back to the Basics” on October 16 and 17.

Future presentations in the series will include Peter Gay, MD and Professor at the Mayo Clinic, discussing ventilation in sleep breathing disorders on November 13 and 14, and Robert Thomas, MD and Professor at Harvard Medical School, reviewing the role of loop gain in sleep breathing disorders on January 8 and 9, 2025.

The first lecture in the series, “Introducing KairosPAP (KPAP): The Future of PAP Therapy for OSA,”* had record attendance among SleepWorld Magazine webinars and was presented in late May by David P. White, MD and Professor at Harvard Medical School. It is available here to watch online at no charge.

With nearly a billion patients worldwide suffering from some level of obstructive sleep apnea (OSA) and new information evolving rapidly around OSA’s physiology, pathophysiology, and treatment, SleepWorld, SleepRes, and the series presenters believe the presentations will prove valuable for any professional caring for these patients.

“The record attendance at our first lecture by Dr. David White shows the immense interest in and need for this kind of educational series,” said Michael DiDomenico, publisher of SleepWorld Magazine. “I can’t wait to see the impact of these future presentations.”

To register for one of Dr. Gottlieb’s August lectures on sleep apnea and CVD, visit Sleep Apnea and Cardiovascular Disease: Could Excessive CPAP Explain the Negative Clinical Trials?.

*Currently, KPAP™ is for investigational use only and is not for sale in the U.S.